Odyssey Health (ODYY) Enterprise Value (QoQ) (2014 - 2026)
Odyssey Health (ODYY) Enterprise Value (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 51.68% |
| Jan 31, 2026 | -2,308.84% |
| Oct 31, 2025 | -34.07% |
| Jul 31, 2025 | -499.00% |
| Apr 30, 2025 | 55.67% |
| Jan 31, 2025 | 86.66% |
| Oct 31, 2024 | -2,164.19% |
| Jul 31, 2024 | 96.40% |
| Apr 30, 2024 | 60.27% |
| Jan 31, 2024 | 16.04% |
| Oct 31, 2023 | -436.77% |
| Jul 31, 2023 | -2,887.44% |
| Apr 30, 2023 | 96.55% |
| Jan 31, 2023 | 29.12% |
| Oct 31, 2022 | 30.38% |
| Jul 31, 2022 | 72.76% |
| Apr 30, 2022 | -102.76% |
| Jan 31, 2022 | 72.12% |
| Oct 31, 2021 | -549.54% |
| Jul 31, 2021 | 94.74% |